Entasis Therapeutics Holdings Inc.
Entasis Therapeutics Holdings Inc. (ETTX) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 106 transactions totaling $171.0M, demonstrating a bullish sentiment with $170.3M in net insider flow. The most recent transaction on Jul 11, 2022 involved a transaction of 150,000 shares valued at $0.
ETTX Insider Activity Summary
Who Is Buying ETTX Stock?
No significant insider buying has been recorded for ETTX in the recent period.
Who Is Selling ETTX Stock?
No significant insider selling has been recorded for ETTX in the recent period.
Is Entasis Therapeutics Holdings Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ETTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $170.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ETTX Frequently Asked Questions
Understanding ETTX Insider Activity
Insider trading at Entasis Therapeutics Holdings Inc. (ETTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading ETTX stock, having executed 106 transactions in the past 90 days. The most active insider is Strategic Opportunities Llc Innoviva (Executive), who has made 3 transactions totaling $54.9M.
Related Tools
Track Entasis Therapeutics Holdings Inc. Insider Activity
Get notified when executives and directors at ETTX file new Form 4 transactions